deltatrials
Terminated PHASE3 NCT00002525

Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

Phase III Intergroup Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection, Followed by 5-FU/Leucovorin for Patients With Colon Cancer

Sponsor: American College of Surgeons

Conditions Colorectal Cancer
Interventions fluorouracil leucovorin calcium
Updated 8 times since 2017 Last updated: Jun 13, 2023 Started: Oct 1, 1993 Primary completion: Feb 28, 2015 Completion: Apr 30, 2015

Listed as NCT00002525, this PHASE3 trial focuses on Colorectal Cancer and remains terminated or withdrawn. Sponsored by American College of Surgeons, it has been updated 8 times since 1993, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jul 2023 — Jul 2024 [monthly]

    Terminated PHASE3

  4. May 2023 — Jul 2023 [monthly]

    Terminated PHASE3

  5. Jan 2021 — May 2023 [monthly]

    Terminated PHASE3

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  2. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE3

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE3

    First recorded

Oct 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • American College of Surgeons
  • Cancer and Leukemia Group B
  • ECOG-ACRIN Cancer Research Group
  • NSABP Foundation Inc
  • National Cancer Institute (NCI)
  • SWOG Cancer Research Network
Data source: Eastern Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Maywood, United States